Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients
Cristina Pellegrini(University of L'Aquila), Giuseppe Palmieri(University of Sassari), Alberto Leva(Politecnico di Milano), Daniela Massi(University of Florence), Lorenza Pastorino(Ospedale Policlinico San Martino), Andrea Maurichi(Fondazione IRCCS Istituto Nazionale dei Tumori), Lisa Elefanti(Istituto Oncologico Veneto), Paola Ghiorzo(Ospedale Policlinico San Martino), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Sara Raimondi(Istituti di Ricovero e Cura a Carattere Scientifico), Chiara Menin(Istituto Oncologico Veneto), Maria Concetta Fargnoli(University of L'Aquila), Gabriella Guida(University of Bari Aldo Moro), Ignazio Stanganelli(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Pietro Quaglino(Department of Medical Sciences), Paola Queirolo, Monica Rodolfo(Fondazione IRCCS Istituto Nazionale dei Tumori), Giulio Tosti(European Institute of Oncology), Maria Ausilia Manganoni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)
Cited by 13
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2017|491
The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
|Archives of Pathology & Laboratory Medicine|2020|485